1. Lacy JH, Wieman TJ, Shively EH. Management of malignant ascites.Surg Gynecol Obstet 159: 397–412, 1984.
2. Chatal JF, Saccavini JC, Gestin JF, Thedrez P, Curtet C, Kremer M, et al. Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.Cancer Res 49: 3087–3094, 1989.
3. Vera DR, Stadalnik RC, Krohn K. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.J Nucl Med 26: 1157–1167, 1985.
4. Kurtaran A, Li SR, Raderer M, Leimer M, Muller C, Pidlich J, et al. Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.J Nucl Med 36: 1875–1881, 1995.
5. Ha-Kawa SK, Tanaka Y, Hasebe S, Kuniyasu Y, Koizumi K, Ishii Y, et al. Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study.Eur J Nucl Med 24: 130–137, 1997.